openPR Logo
Press release

Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017

10-25-2017 01:00 PM CET | Health & Medicine

Press release from: Arizton Advisory & Intelligence

Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017

Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017

“Tumor Necrosis Factor Alpha (TNF-a) Inhibitors-Pipeline Insights 2017″, report provides comprehensive analysis of TNF-a drug candidates currently undergoing clinical trials. The report covers detailed drug profiles of potential TNF-a inhibitors across various clinical development phases including – discovery, pre-clinical, IND, Phase I, Phase II, Phase III and Pre-registration. Report also includes the pipeline products’ clinical trial data along with information on other development activities including technology, licensing, collaborations, acquisitions, funding, patent and USFDA & EMA designations. Report also assesses the pipeline TNF-a inhibitors by monotherapy, combination products, molecule type and route of administration. In addition to analysis on active pipeline molecules, the report also provides detailed information on the discontinued and dormant drugs.

View report:https://www.arizton.com/reports/pharma-pipeline-analysis/tumor-necrosis-factor-alpha-tnf-a-inhibitors-pipeline-insights

Key players developing potential TNF-a drug candidates have been profiled in the report. Each of the company profile provides details such as company overview, business overview, financial overview, product portfolio, business strategies, and recent developments.

Advent Tumor Necrosis Factor Alpha (TNF-a) inhibitors represent one a major treatment paradigm for inflammatory diseases. Anti TNF-a drug class one of the most commercially successful drug classes in the pharmaceutical industry worldwide. Currently marketed anti-TNF-a drugs are among the top five global block buster drugs. Cumulative sales of top three TNF-a inhibitors (Remicade, Enbrel, Humira) surpassed $32 billion in 2016.

TNF-a inhibitors exhibit therapeutic efficacy blocking the activity of tumor necrosis factor (TNF), a cytokine that causes inflammation and leads to diverse immune-system diseases. Apparently, almost all the currently marketed TNF-a drugs are indicated for wide spectrum of immune-related disorders such as – Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis and uveitis. Advances in biological research is uncovering further therapeutic benefits of this drug class for wider indications. Currently clinical research is focused on evaluating therapeutic efficacy and safety of TNF-a inhibitors on wide range of other inflammatory diseases, neurodegenerative diseases and multiple cancers.

Reasons to buy

To gain erudite insights on TNF-a inhibitor pipeline landscape
Ascertain unique product development dynamics and leverage it for novel target identification, drug repositioning and precision medicine.

For optimization of pipeline product portfolio in correspondence with ever dynamic pharmaceutical market

Identify competitors and design strategic initiatives for drug development activities

To understand the market and choose right partners for strategic collaborations

To obtain well-informed updates on drug termination/drug discontinuations

Related Reports

1) Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017

https://www.arizton.com/reports/pharma-pipeline-analysis/histone-deacetylase-hdac-inhibitors-pipeline-insights

2) Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Pipeline Insights 2017
https://www.arizton.com/reports/pharma-pipeline-analysis/chimeric-antigen-receptor-car-t-cell-immunotherapy-pipeline-insights-2017

About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017 here

News-ID: 785375 • Views:

More Releases from Arizton Advisory & Intelligence

The Global Fetal Doppler Market to Reach $277.82 Million by 2028 - Arizton
The Global Fetal Doppler Market to Reach $277.82 Million by 2028 - Arizton
Arizton is pleased to announce its latest report, fetal doppler market - global outlook & forecast 2023-2028, shedding light on the dynamic and rapidly evolving industry. The comprehensive report unveils valuable market trends, growth opportunities, and the competitive landscape of the business. With in-depth analysis and meticulous research, this report serves as a strategic guide for industry players, investors, and decision-makers, offering a comprehensive understanding of the current fetal doppler market dynamics
The Global Disinfection Robots Market to Reach $1.41 Billion by 2028 - Arizton
The Global Disinfection Robots Market to Reach $1.41 Billion by 2028 - Arizton
Arizton is pleased to announce its latest report, disinfection robots market - global outlook & forecast 2023-2028, shedding light on the dynamic and rapidly evolving industry. The comprehensive report unveils valuable market trends, growth opportunities, and the competitive landscape of the business. With in-depth analysis and meticulous research, this report serves as a strategic guide for industry players, investors, and decision-makers, offering a comprehensive understanding of the current disinfection robots market dynamics
The Europe Disposable Gloves Market to Reach $12.70 Billion by 2029 - Arizton
The Europe Disposable Gloves Market to Reach $12.70 Billion by 2029 - Arizton
According to Arizton's latest research report, the Europe disposable gloves market will grow at a CAGR of 7.71% during 2023-2029. The Europe disposable gloves market caters to various industries, including healthcare, food & beverage, pharmaceuticals, manufacturing, and cleaning & sanitation services. Each industry segment has distinct requirements, influencing the type of disposable gloves used. However, the healthcare sector contributes significantly to the market's growth. The market is characterized by intense
The Global Nutraceuticals Market To Reach $693.06 Billion by 2028- Arizton
The Global Nutraceuticals Market To Reach $693.06 Billion by 2028- Arizton
Arizton is pleased to announce its latest report, nutraceuticals market - global outlook & forecast 2023-2028, shedding light on the dynamic and rapidly evolving industry. The comprehensive report unveils valuable market trends, growth opportunities, and the competitive landscape of the business. With in-depth analysis and meticulous research, this report serves as a strategic guide for industry players, investors, and decision-makers, offering a comprehensive understanding of the current nutraceuticals market dynamics and

All 5 Releases


More Releases for TNF

TNF Inhibitors Global Industry Report - History, Present and Future 2025
The global market size of TNF Inhibitors is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented
TNF Inhibitors Market information related to pipeline products, news and deals
MarketResearchReports.Biz adds “Global TNF Inhibitors Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the TNF Inhibitors and the growth estimates for the forecasted period. The TNF inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global TNF inhibitors market. The anti-TNF drugs are among the top 10 global blockbuster drugs and have dominated the global pharmaceutical
TNF Inhibitors Market Key Drivers & On-going Trends 2017 – 2025
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflammation-causing substance. TNF inhibitor drugs are employed to treat inflammatory conditions such as rheumatoid arthritis and juvenile arthritis. Generally, in the healthy person, the TNF
TNF Inhibitors Market Key Drivers & On-going Trends 2017 - 2025
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflammation-causing substance. View Report- https://www.transparencymarketresearch.com/tnf-inhibitors-market.html TNF inhibitor drugs are employed to treat inflammatory conditions such as rheumatoid arthritis and juvenile arthritis. Generally, in the healthy person, the
TNF Inhibitors - A Pipeline Analysis Report
"The Report TNF Inhibitors - A Pipeline Analysis Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" TNF Inhibitors: An insight The TNF inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global TNF inhibitors market. The anti-TNF drugs are among the top 10 global blockbuster drugs and have dominated the global pharmaceutical market landscape for many years. The report
Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017
“Tumor Necrosis Factor Alpha (TNF-a) Inhibitors-Pipeline Insights 2017″, report provides comprehensive analysis of TNF-a drug candidates currently undergoing clinical trials. The report covers detailed drug profiles of potential TNF-a inhibitors across various clinical development phases including – discovery, pre-clinical, IND, Phase I, Phase II, Phase III and Pre-registration. Report also includes the pipeline products’ clinical trial data along with information on other development activities including technology, licensing, collaborations, acquisitions, funding,